Syra Health Statistics
Total Valuation
Syra Health has a market cap or net worth of 3.26 million. The enterprise value is 1.79 million.
| Market Cap | 3.26M |
| Enterprise Value | 1.79M |
Important Dates
The last earnings date was Thursday, March 12, 2026.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Syra Health has 17.34 million shares outstanding. The number of shares has increased by 56.95% in one year.
| Current Share Class | 11.34M |
| Shares Outstanding | 17.34M |
| Shares Change (YoY) | +56.95% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 38.71% |
| Owned by Institutions (%) | n/a |
| Float | 6.81M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| PB Ratio | 1.55 |
| P/TBV Ratio | 1.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.00 |
| EV / Sales | 0.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.99 |
Financial Position
The company has a current ratio of 4.06, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.06 |
| Quick Ratio | 3.75 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.32 |
| Interest Coverage | -68.15 |
Financial Efficiency
Return on equity (ROE) is -36.02% and return on invested capital (ROIC) is -20.29%.
| Return on Equity (ROE) | -36.02% |
| Return on Assets (ROA) | -17.52% |
| Return on Invested Capital (ROIC) | -20.29% |
| Return on Capital Employed (ROCE) | -43.10% |
| Weighted Average Cost of Capital (WACC) | 25.22% |
| Revenue Per Employee | 95,079 |
| Profits Per Employee | -11,794 |
| Employee Count | 94 |
| Asset Turnover | 2.24 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.01% in the last 52 weeks. The beta is 3.96, so Syra Health's price volatility has been higher than the market average.
| Beta (5Y) | 3.96 |
| 52-Week Price Change | -45.01% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.09 |
| Relative Strength Index (RSI) | 87.35 |
| Average Volume (20 Days) | 17,785 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.96 |
Income Statement
In the last 12 months, Syra Health had revenue of 7.23 million and -896,333 in losses. Loss per share was -0.08.
| Revenue | 7.23M |
| Gross Profit | 2.49M |
| Operating Income | -904,324 |
| Pretax Income | -896,333 |
| Net Income | -896,333 |
| EBITDA | -880,096 |
| EBIT | -904,324 |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 1.61 million in cash and 143,787 in debt, with a net cash position of 1.47 million or 0.08 per share.
| Cash & Cash Equivalents | 1.61M |
| Total Debt | 143,787 |
| Net Cash | 1.47M |
| Net Cash Per Share | 0.08 |
| Equity (Book Value) | 2.10M |
| Book Value Per Share | 0.12 |
| Working Capital | 2.06M |
Cash Flow
In the last 12 months, operating cash flow was -447,746 and capital expenditures -107, giving a free cash flow of -447,853.
| Operating Cash Flow | -447,746 |
| Capital Expenditures | -107 |
| Free Cash Flow | -447,853 |
| FCF Per Share | -0.03 |
Margins
Gross margin is 34.43%, with operating and profit margins of -12.51% and -12.40%.
| Gross Margin | 34.43% |
| Operating Margin | -12.51% |
| Pretax Margin | -12.40% |
| Profit Margin | -12.40% |
| EBITDA Margin | -12.18% |
| EBIT Margin | -12.51% |
| FCF Margin | n/a |
Dividends & Yields
Syra Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -56.95% |
| Shareholder Yield | -56.95% |
| Earnings Yield | -27.50% |
| FCF Yield | -13.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Syra Health has an Altman Z-Score of 0.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.1 |
| Piotroski F-Score | 3 |